From: Results from a large targeted screening program for alpha-1-antitrypsin deficiency: 2003 - 2015
 | Detection rate [%] | Age [years] | Male/female | Most frequent clinical characteristics |
---|---|---|---|---|
2003/04/05 | 8.65 | 39.8 ± 21.9 | 1105/887 | 1. Cough |
2. Emphysema | ||||
3. Wheezing | ||||
2006/07 | 4.04 | 40.4 ± 21.7 | 1527/1399 | 1. Dyspnoea on exertion |
2. Cough | ||||
3. Wheezing | ||||
2008/09 | 4.25 | 48.9 ± 21.6 | 1973/1791 | 1. Dyspnoea on exertion |
2. Cough | ||||
3. Phlegm | ||||
2010/11 | 4.98 | 48.2 ± 20.3 | 2127/1888 | 1. Dyspnoea on exertion |
2. Cough | ||||
3. Phlegm | ||||
2012/13 | 7.91 | 47.9 ± 19.1 | 1808/1661 | 1. Dyspnoea on exertion |
2. Cough | ||||
3. COPD | ||||
2014/15 | 11.26 | 48.5 ± 18.8 | 1280/1139 | 1. Dyspnoea on exertion |
2. COPD | ||||
3. Cough | ||||
All | 6.85 | 45.9 ± 20.8 | 9820/8765 | 1. Dyspnoea on exertion |
2. Cough | ||||
3. COPD |